Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Layton

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
HGG Advances|December 18, 2024
An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndromeTess Levy, J Lloyd Holder, Joseph P Horrigan, et al.
HGG Advances|September 19, 2022
An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndromeAlexander Kolevzon, Tess Levy, Sarah Barkley, et al.
Genes|March 6, 2021
Sensory Reactivity Symptoms Are a Core Feature of ADNP Syndrome Irrespective of Autism DiagnosisPaige M Siper, Christina Layton, Tess Levy, et al.
Human Molecular Genetics|September 24, 2021
Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortiumTess Levy, Jennifer H Foss-Feig, Catalina Betancur, et al.
Molecular Autism|May 17, 2021
Prospective and detailed behavioral phenotyping in DDX3X syndromeLara Tang, Tess Levy, Sylvia Guillory, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
HGG Advances|December 18, 2024
An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndromeTess Levy, J Lloyd Holder, Joseph P Horrigan, et al.
HGG Advances|September 19, 2022
An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndromeAlexander Kolevzon, Tess Levy, Sarah Barkley, et al.
Genes|March 6, 2021
Sensory Reactivity Symptoms Are a Core Feature of ADNP Syndrome Irrespective of Autism DiagnosisPaige M Siper, Christina Layton, Tess Levy, et al.
Human Molecular Genetics|September 24, 2021
Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortiumTess Levy, Jennifer H Foss-Feig, Catalina Betancur, et al.
Molecular Autism|May 17, 2021
Prospective and detailed behavioral phenotyping in DDX3X syndromeLara Tang, Tess Levy, Sylvia Guillory, et al.
Pageof 2